Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults

Digestion. 2008;78(1):24-9. doi: 10.1159/000152844. Epub 2008 Sep 4.

Abstract

Background: Partially hydrolyzed guar gum (PHGG) is a water-soluble fiber if added to oral rehydration solution (ORS) and undergoes fermentation in the colon liberating short chain fatty acids (SCFAs). SCFAs potentiate the effect of ORS, reducing the severity of diarrhea.

Aim: To examine the effect of PHGG-added ORS in reducing the stool output and duration of diarrhea in adult cholera.

Methods: 195 male patients were studied in a randomized controlled trial: (a) 65 received ORS + 25 g PHGG; (b) 65 received ORS + 50 g PHGG, and (c) 65 received ORS alone (control). Major outcomes were stool weight and duration of diarrhea.

Results: No significant differences were found in mean +/- SD stool weight (g/kg b.w.) during the first and second 24 h. In the subgroup analysis (excluding very high purging patients, stool weight in the first 24 h was >10 kg), the stool weight (g/kg b.w.) was significantly reduced in the first 24 h in both groups receiving PHGG (PHGG 25 g, 136 +/- 68 vs. PHGG 50 g, 144 +/- 49 vs. control, 176 +/- 43, p = 0.01).

Conclusion: PHGG-added ORS might have a beneficial effect in moderately purging adult cholera. However, further studies are warranted to confirm the preliminary findings.

Trial registration: ClinicalTrials.gov NCT00672308.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antidiarrheals / therapeutic use
  • Cholera / drug therapy*
  • Diarrhea / drug therapy
  • Feces / microbiology
  • Fluid Therapy*
  • Galactans / therapeutic use*
  • Humans
  • Male
  • Mannans / therapeutic use*
  • Middle Aged
  • Plant Gums / therapeutic use*
  • Vibrio cholerae / isolation & purification
  • Young Adult

Substances

  • Antidiarrheals
  • Galactans
  • Mannans
  • Plant Gums
  • guar gum

Associated data

  • ClinicalTrials.gov/NCT00672308